Crossref
Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors
Nucleic Acid Insights · 2024
DOI: 10.18609/nai.2024.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Insights, 2024. Verfasst von Hartaj Singh.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Singh, H. (2024). Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors. Nucleic Acid Insights. https://doi.org/10.18609/nai.2024.006
Vancouver
Singh H. Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors. Nucleic Acid Insights. 2024. doi:10.18609/nai.2024.006
BibTeX
@article{Singh2024,
author = {Singh, Hartaj},
title = {Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors},
journal = {Nucleic Acid Insights},
year = {2024},
doi = {10.18609/nai.2024.006}
}
EUVIMED